作者
Sonam Vijay, Nitin Bansal, Brijendra Kumar Rao, Balaji Veeraraghavan, Camilla Rodrigues, Chand Wattal, Jagdish Prasad Goyal, Karuna Tadepalli, Purva Mathur, Ramanathan Venkateswaran, Ramasubramanian Venkatasubramanian, Sagar Khadanga, Sanjay Bhattacharya, Sudipta Mukherjee, Sujata Baveja, Sujatha Sistla, Samiran Panda, Kamini Walia
发表日期
2021/5/24
期刊
Infection and drug resistance
页码范围
1893-1903
出版商
Taylor & Francis
简介
Purpose
Critically ill coronavirus disease 2019 (COVID-19) patients need hospitalization which increases their risk of acquiring secondary bacterial and fungal infections. The practice of empiric antimicrobial prescription, due to limited diagnostic capabilities of many hospitals, has the potential to escalate an already worrisome antimicrobial resistance (AMR) situation in India. This study reports the prevalence and profiles of secondary infections (SIs) and clinical outcomes in hospitalized COVID-19 patients in India.
Patients and Methods
A retrospective study of secondary infections in patients admitted in intensive care units (ICUs) and wards of ten hospitals of the Indian Council of Medical Research (ICMR) AMR surveillance network, between June and August 2020, was undertaken. The demographic data, time of infection after admission, microbiological and antimicrobial resistance data of secondary infections, and …
学术搜索中的文章
S Vijay, N Bansal, BK Rao, B Veeraraghavan… - Infection and drug resistance, 2021